GSK Investigational Site

Southampton, Hampshire SO16 6YD

0 studies enrolling now · 6 studies all time

What they study most

Asthma, BRCA1 Gene Mutation, BRCA2 Gene Mutation, Carcinoma of Breast, Herpes Simplex, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Neoplasms, Breast, Neoplasms, Prostate, Ovarian Neoplasms, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients — Stopped early
• Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old — Completed
• A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study Of Ispinesib In Subjects With Breast Cancer — Completed
• Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed